| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $668.2M | +7.8% |
| Cost of Revenue | $258.8M | -36.9% |
| R&D Expense | $95.2M | +1.0% |
| SG&A Expense | $96.9M | +8.8% |
| Operating Income | $51.1M | +133.0% |
| Interest Expense | $40.4M | -7.0% |
| Pre-tax Income | $26.5M | +116.8% |
| Income Tax | $3.7M | +125.9% |
| Net Income | $22.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $483.2M | +48.1% |
| Accounts Receivable | $1.20B | +2.0% |
| Current Assets | $1.70B | +11.8% |
| Total Assets | $2.85B | +6.2% |
| Current Liabilities | $1.50B | +6.7% |
| Long-term Debt | $553.7M | +3.2% |
| Total Liabilities | $2.09B | +5.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $235.2M | +9.7% |
| Capital Expenditures | $32.8M | +22.6% |
| Investing Cash Flow | -$47.5M | -27.1% |
| Financing Cash Flow | -$28.9M | +83.7% |
| Free Cash Flow | $202.4M | +7.9% |
| +114.3% |
| EPS (Basic) | $0.16 | +113.7% |
| EPS (Diluted) | $0.16 | +113.7% |
| Stockholders' Equity |
| $768.2M |
| +9.5% |